eyeball, a wire needs to be led out through the flat part
of the ciliary body. The current surface artificial
retina requires an external system for image
acquisition, image processing, data and power
conversion to the implant, so this information
conversion is more easily controlled by the outside
world. The composition of this device is a very small
field sensor like a camera, which is fixed outside the
eyeball or inside a plastic lens implanted in cataract
surgery. Moreover, a platinum-wrapped metal wire
connects it to the electrode arrangement on the top of
the inner retina. stand up. The implant on the retina is
first a readout chip, which receives the image
information from the sensor and the electrical signal
from the processing unit to generate electrical
impulses, which stimulate the axons of the ganglion
cells and pass into the brain through the axons.
A clinical trial of a retinal surface stimulator
approved by the FDA has recently begun. An
exclusive clinical trial is also underway at the Doheny
Retina Institute at the University of Southern
California, and 2 patients have received implants.
Studies have confirmed that microelectronic devices
have enough energy to directly stimulate retinal
neurons, so that patients who are completely blind can
feel the light consistent with the stimulation pulse.
Each electrode is controllable. Under the control of a
microelectronic device, when each electrode is
activated, it can cause light perception. In Germany,
the researchers temporarily placed a stimulating
device on the retina of a test subject (before eye
surgery, with normal photoreceptors, not blind). The
results showed that there was light under a very low
stimulation current. These results supports the results
of previous preclinical trials of multiple research
groups. What is more, in the case of outer retinal
degeneration, the retina requires higher current
stimulation, which is more difficult to stimulate than
the healthy retina without loss of photoreceptors
(Zhou et al. 2007).
2.2 Subretinal Prosthesis
Subretinal prosthesis is implanted between the retinal
pigment epithelium and the sensory layer of the
retina. The advantage is that the implanted electrodes
are close to the retinal bipolar cells, the stimulation
current required is small. Some devices are designed
to directly generate stimulus current from light
without an external power source; while others are
designed with an external power source to amplify the
electrical signal generated by the light. This device is
composed of thousands of microelectrodes,
containing photosensitive micro photodiodes,
integrated on a very thin board (thickness 50-100μm,
diameter 2-3mm). The photodiode is irradiated by
light and converted into a tiny current on each
microelectrode. The current is "injected" into the
remaining neurons of the retina, and the middle and
inner layers of the retina serve as the processing part
of visual information. In addition, coating
glycoproteins (such as laminin) on the surface of the
micro-photodiode can increase biocompatibility.
Besides, optobionics has been approved by the FDA
for clinical trials using artificial silicon retinas in
recent years (Hauer et al. 2007). This device is an
array of micro-photodiodes, implanted in the
subretinal space, and powered by light only. In June
2000 and July 2001, 3 people received implants on 2
occasions. It was reported at the ARVO meeting in
2002 that the implant still had electrical function and
remained in place, which could indirectly improve
visual function, but under normal light conditions, the
device itself could not directly activate the retina.
Researchers such as the University of Tubingen in
Germany have also developed a device. They
confirmed that in the long-term loss of photoreceptors
in the retina, passive light reception cannot generate
enough current to induce a direct response of retinal
neurons. In order to solve this problem, they used
external infrared energy to provide greater energy to
the implant to generate electrical stimulation pulses.
In addition to the energy supply device, the micro
photodiode located under the retina can receive light
and transmit stimulation pulses to the stimulation
electrodes under the retina. Recently, a research
group at the University of Houston used ceramic
optoelectronic materials to make implants. Japan's
Nidek Co., Ltd. produced a subretinal electrode array
with a wire connected to the electronic device in the
vitreous cavity through the retina (shown in Figure 2)
(Gu et al. 2020). Chemical prosthesis method can
release neurotransmitters in the target area of the
retina has been proposed, but its feasibility is still at
the stage of demonstration. The Kresge Institute of
Ophthalmology at Wayne State University has
proposed a microfluidic device that can be used to
stimulate the cortex and retina which can stimulate
neurons.